The dose of the corresponding GLP-1RA was prescribed according to the manufacturers instructions on titration of the dose up to the highest tolerated dose
And by affecting appetite so dramatically, it can lead to nutritional deficiencies if you are not careful about what you eat while on tirzepatide
5 Figure 3: Pharmacy claims data show that 63% of patients initiating Wegovy or Zepbound in early 2024 remained on therapy at one year, up from 40% in the 2023 cohort
Patients need to understand that distinction
However, there is a lack of research data on the impact of semaglutide in vitro and in vivo , which limits its efficiency in tumor therapy
Importantly, experiencing headaches during tirzepatide treatment does not mean the medication is wrong for youmost patients tolerate it well once the initial phase passes, and the weight loss and metabolic benefits often outweigh temporary discomfort